2 terminated. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 2 |
| Phase 1 | 1 | Terminated 1 |
Follow SBRT: new trials by email Literature Review of SBRT trials Research Report on SBRT
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 2b Study of GC4711 in Combination With SBRT for Nonmetastatic Pancreatic Cancer Drug GC4711, Placebo - SBRT, Borderline Resectable Pancreatic Cancer | Phase 2 | Terminated | Galera Therapeutics, Inc. | 177 | 2021-05-07 | 2024-05-21 |
| Phase I/II Study of SBRT and GC4711 for Centrally Located or Large NSCLC GC4711 +SBRT, Placebo +SBRT - SBRT, NSCLC | Phase 1 / Phase 2 | Terminated | Galera Therapeutics, Inc. | 47 | 2020-10-18 | 2024-04-30 |
United States (2) · Canada (1) · France (1) · United Kingdom (1)